Extended Resections of Liver Metastases from Colorectal Cancer

Jonas, S.; Thelen, A.; Benckert, C.; Spinelli, A.; Sammain, S.; Neumann, U.; Rudolph, B.; Neuhaus, P.
March 2007
World Journal of Surgery;Mar2007, Vol. 31 Issue 3, p511
Academic Journal
Indications for resection of liver metastases from colorectal cancer and surgical strategies are still under debate. We have retrospectively reviewed the outcome of 660 patients after 685 liver resections for metastases of colorectal cancer in our institution from 1988 to 2004. All surviving patients have a minimum follow-up period of 1 year. The longest follow-up in these patients is 16 years. Three different time periods of 5 to 6 years each were analyzed. The 30- and 60-day mortality rates were 1.5% ( n = 10) and 2.2 % ( n = 15), respectively. The rate of formally curative (R0) resections was 84%. Five-year survival rates in all patients and in patients after R0 resection were 37% and 42%, respectively. If only resections from 1999 to 2004 were considered, 5-year survival in patients after R0 resection was 50%. In a multivariate analysis, surgical radicality, ligamental lymph node involvement, number of liver metastases, and time period, in which the liver resection had been performed, were independent prognostic parameters. Outcome after liver resection for metastases from colorectal cancer has constantly improved. A formally curative resection is the most relevant prognostic parameter. Number of liver metastases and, in the few patients concerned, lymph node infiltration of the hepatoduodenal ligament, were further prognostic parameters.


Related Articles

  • Predictors and outcome of early recurrence after resection of hepatic metastases from colorectal cancer. Kaibori, Masaki; Iwamoto, Yoshinori; Ishizaki, Morihiko; Matsui, Kosuke; Yoshioka, Kazuhiko; Asano, Hiroaki; Kwon, A-Hon // Langenbeck's Archives of Surgery;Mar2012, Vol. 397 Issue 3, p373 

    Purpose: This study aimed to investigate the risk factors for early recurrence in patients who had undergone curative resection of colorectal liver metastases (CRLM) and to evaluate the outcome after recurrence. Methods: A total of 119 patients were divided into 2 groups: an early recurrence...

  • Synchronous Resection of Colorectal Primary Cancer and Liver Metastases. Yan, Tristan D.; Chu, Francis; Black, Deborah; King, Denis W.; Morris, David L. // World Journal of Surgery;Jul2007, Vol. 31 Issue 7, p1496 

    Patients with synchronous colorectal liver metastases are thought to have a less favorable prognosis than those with colorectal cancer alone. Surgical treatment options are controversial, be it synchronous resection or staged resection. This study compared the clinical, perioperative,...

  • Timing of resection for synchronous liver metastases from colorectal cancer. Kaibori, Masaki; Iwamoto, Shigeyoshi; Ishizaki, Morihiko; Matsui, Kosuke; Saito, Takamichi; Yoshioka, Kazuhiko; Hamada, Yoshinori; Kwon, A.; Kwon, A Hon // Digestive Diseases & Sciences;Nov2010, Vol. 55 Issue 11, p3262 

    Background: This study aimed to compare the surgical outcome and long-term survival between simultaneous and delayed resection of liver metastases from colorectal cancer (LM), and to identify the factors influencing hepatic disease-free survival in patients with synchronous...

  • Parenchyma-preserving hepatic resection for colorectal liver metastases. Heesen, Maximilian; Schuld, Jochen; Sperling, Jens; Grünhage, Frank; Lammert, Frank; Richter, Sven; Schilling, Martin; Kollmar, Otto // Langenbeck's Archives of Surgery;Mar2012, Vol. 397 Issue 3, p383 

    Background: Hepatic resection of colorectal liver metastases is the only curative treatment option. As clinical and experimental data indicate that the extent of liver resection correlates with growth of residual metastases, the present study analyzes the potential benefit of a...

  • Survival after Lung Metastasectomy in Colorectal Cancer Patients with Previously Resected Liver Metastases. Gonzalez, Michel; Robert, John; Halkic, Nermin; Mentha, Gilles; Roth, Arnaud; Perneger, Thomas; Ris, Hans; Gervaz, Pascal // World Journal of Surgery;Feb2012, Vol. 36 Issue 2, p386 

    Background: Resection of hepatic metastases is indicated in selected stage IV colorectal cancer (CRC) patients. A minority will eventually develop pulmonary metastases and may undergo lung surgery with curative intent. The aims of the present study were to assess clinical outcome and identify...

  • Resection of Colorectal Liver Metastases: Is a Resection Margin of 3 mm Enough? Konopke, Ralf; Kersting, Stephan; Makowiec, Frank; Gaßmann, Peter; Kuhlisch, Eberhard; Senninger, Norbert; Hopt, Ulrich; Detlev Saeger, Hans // World Journal of Surgery;Sep2008, Vol. 32 Issue 9, p2047 

    A safety margin of ≥10 mm is generally accepted in surgery for colorectal metastases. It is reasonable that modern methods of liver parenchyma dissection may allow for a reduction in this distance. A total of 333 patients were included in a multicenter trial after resection of colorectal...

  • Impact of the Degree of Liver Resection on Survival for Patients with Multiple Liver Metastases from Colorectal Cancer. Tanaka, Kuniya; Shimada, Hiroshi; Matsumoto, Chizuru; Matsuo, Kenichi; Takeda, Kazuhisa; Nagano, Yasuhiko; Togo, Shinji // World Journal of Surgery;Sep2008, Vol. 32 Issue 9, p2057 

    Although the degree of hepatic resection has been found to be a key aspect of tumor stimulation, the differences in clinical outcome between a massive liver resection and a less extensive resection for multiple colorectal metastases have not been well studied. The purpose of this study was to...

  • HEPATIC ARTERIAL INFUSION FOR METASTATIC COLORECTAL CANCER: THE PRICE OF "SUCCESS" Ruffin, W. Kirkland; Johnson, David // American Journal of Gastroenterology;Nov1996, Vol. 91 Issue 11, p2444 

    Provides information on the hepatic arterial infusion in the treatment of nonresectable liver metastases from colon cancer. Percentage of the blood supply obtained by metastases from the arterial circulation; Average patient survival of liver-only metastases from colon cancer; Rate of the...

  • Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer. Onodera, Hisashi; Mori, Akira; Nagayama, Satoshi; Fujimoto, Akihisa; Tachibana, Tsuyoshi; Yonenaga, Yoshikuni; Tsuruyama, Tatsuaki // International Journal of Colorectal Disease;Nov2005, Vol. 20 Issue 6, p477 

    Background: The selection of resective therapy for colorectal hepatic metastases remains controversial. The aim of this study is to investigate the prognostic factors for patients with resected liver metastases from colorectal cancer by analyzing not only clinicopathological factors but also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics